Last Price
0.18
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Market Cap
778 Million
Shares Outstanding
4 Billion
Avg Volume
4,091,356
Avg Price (50 Days)
0.12
Avg Price (200 Days)
0.10
PE Ratio
-18.00
EPS
-0.01
Earnings Announcement
27-Feb-2025
Previous Close
0.15
Open
0.16
Day's Range
0.155 - 0.185
Year Range
0.052 - 0.185
Trading Volume
23,592,393
1 Day Change
16.13%
5 Day Change
24.14%
1 Month Change
38.46%
3 Month Change
44.00%
6 Month Change
122.22%
Ytd Change
80.00%
1 Year Change
200.00%
3 Year Change
33.33%
5 Year Change
323.22%
10 Year Change
1355.84%
Max Change
-15.62%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for kidney, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders, including Motor Neurone Disease. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.